We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BATS:LSEBritish American Tobacco p.l.c. Analysis

Data as of 2026-06-06 - not real-time

£4,404.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

British American Tobacco trades around £44.04 (4404 GBp) and sits comfortably above its 20‑day and 50‑day SMAs (4672.8 GBp and 4447.2 GBp) while still below the 200‑day SMA (4265.2 GBp), indicating a bullish momentum that is supported by an increasing volume trend. The RSI of 41.6 suggests the stock is not yet oversold, and the MACD histogram remains deeply negative, flagging short‑term bearish pressure despite the broader bullish trend. Volatility over the past 30 days is moderate at 32.5 % and beta is exceptionally low (≈0.09), underscoring the defensive nature of the consumer‑defensive tobacco sector. Fundamentals show a solid P/E of 12.6, a robust dividend yield of 5.56 % with a payout ratio near 69 %, and free cash flow comfortably covering dividend obligations, which supports the sustainability of the payout. The DCF‑derived fair value (~£3.91) is far below the current price, but analyst consensus (11 analysts, “buy”) targets a median price of £52.00, implying a potential upside of roughly 14 % from today’s level. Recent commentary on Seeking Alpha highlights the stock’s “6 % yield remains my largest holding,” reinforcing the attractiveness of the dividend in a low‑growth environment. Share price has modestly retreated over the past week (‑4.7 %) and month (‑3.9 %), offering a modest entry point before the anticipated upside. Overall, the company’s strong operating margins (34.6 %), high gross margin (82.7 %), and resilient cash generation position it well against economic downturns. The regulatory landscape for tobacco remains a headwind, yet the diversified product portfolio (vape, heated, oral nicotine) provides growth avenues. In summary, the stock combines defensive stability, attractive yield, and upside potential, but short‑term technicals caution against aggressive buying.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating near‑term downside pressure
  • Increasing volume supporting potential bounce from support at 3894 GBp
  • Strong dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst median target price of £52.00 suggesting ~14 % upside
  • Robust cash flow and sustainable dividend supporting total return
  • Defensive sector positioning with modest revenue growth

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified nicotine product pipeline (vape, heated, oral) driving future growth
  • Consistently high operating margins and ROE (~15.8 %)
  • Attractive dividend yield in a low‑growth, recession‑resilient industry

Key Metrics & Analysis

Financial Health

Revenue Growth0.10%
Profit Margin30.32%
P/E Ratio12.6
ROE15.82%
ROA5.34%
Debt/Equity72.84
P/B Ratio2.1
Op. Cash Flow£6.3B
Free Cash Flow£3.0B

Technical Analysis

TrendBullish
RSI41.6
Support£3,894.00
Resistance£5,326.00
MA 20£4,672.80
MA 50£4,447.18
MA 200£4,265.20
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02

Valuation

Fair Value£391.14
Target Price£5,022.73
Upside/Downside14.05%
GradeFair
TypeBlend
Dividend Yield5.56%

Risk Assessment

Beta0.09
Volatility32.46%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.